![logo](/logos/BIOWKS.ST.webp)
Bio-Works Technologies AB (publ)
SSE:BIOWKS.ST
4.85 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Bio-Works Technologies AB (publ) |
Symbool | BIOWKS.ST |
Munteenheid | SEK |
Prijs | 4.85 |
Beurswaarde | 189,052,030 |
Dividendpercentage | 0% |
52-weken bereik | 4.7 - 23.5 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jonathan Royce |
Website | https://www.bio-works.com |
An error occurred while fetching data.
Over Bio-Works Technologies AB (publ)
Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)